Welcome to our dedicated page for Cohen & Steers SEC filings (Ticker: CNS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Locating AUM shifts, fee margin details and REIT exposure inside Cohen & Steers’ 300-page disclosures can feel like searching for a needle in a footnote. If you have ever asked, “How do I read the Cohen & Steers annual report 10-K simplified?” or “Where are the Cohen & Steers insider trading Form 4 transactions listed in real time?”, you already know how complex an asset-manager filing can be.
Stock Titan solves that problem. Our AI instantly turns every new Cohen & Steers quarterly earnings report 10-Q filing, 8-K event notice or Cohen & Steers proxy statement executive compensation into plain-English insights. Need to monitor Cohen & Steers Form 4 insider transactions real-time? Want a concise Cohen & Steers earnings report filing analysis that flags AUM growth, fee rate changes and segment performance across liquid real assets? Our platform answers those questions while the document is still hitting EDGAR.
Here is what you can expect the moment CNS files:
- AI-powered summaries that explain complex sections—perfect for understanding Cohen & Steers SEC documents with AI.
- Real-time alerts on executive stock transactions, so you never miss Cohen & Steers executive stock transactions Form 4.
- Line-by-line highlights of 10-K risk factors tied to property cycles, infrastructure regulation and preferred-security credit risk.
- Easy navigation to 8-K items—material fund launches or AUM updates—so Cohen & Steers 8-K material events explained becomes a single click.
Whether you track insider sentiment before allocating capital, compare quarter-over-quarter AUM growth, or dissect fee income trends, our AI lets you move from data to decision faster. Make informed portfolio calls without sifting through hundreds of pages—everything you need from Cohen & Steers SEC filings explained simply is right here.
Cohen & Steers, Inc. (CNS)22,903 shares of common stock, held directly.
The reported amount includes 22,391 restricted stock units that were previously granted by the company to the reporting person. No derivative securities such as options or warrants are listed as beneficially owned in the tables provided.
Cohen & Steers, Inc. (CNS) — Form 4 insider activity: Executive Chairman, Director, and 10% owner Robert H. Steers reported a series of open‑market purchases (code P) of CNS common stock on 11/03/2025, 11/04/2025, and 11/05/2025 at weighted average prices listed in the filing.
Through the Robert H. Steers 2018 Revocable Trust, purchases included 19,856 shares at $68.15, 1,294 at $68.66, 27,292 at $67.95, 642 at $68.39, and 19,329 at $67.61, with beneficial ownership shown as 7,128,497 shares following the last reported transaction. The Hilltop GST Non‑Exempt Descendants' Trust reported 17,200 shares at $68.21, 300 at $68.65, and 14,975 at $67.96, with 3,891,184 shares owned following the last entry.
Additional reported holdings include 805,920 shares by The Sunnyridge GST Exempt Family Trust, 334 shares by the Hamilton‑Steers 2017 Trust FB Robert H. Steers, and 139,747 shares held directly. Footnotes state Mr. Steers disclaims beneficial ownership of certain trust‑held shares except to the extent of his pecuniary interest.
Cohen & Steers (CNS) reported Q3 2025 results with revenue of $141.7 million, up 6.4% year over year, and diluted EPS of $0.81 versus $0.77. Operating income rose to $48.9 million and the operating margin improved to 34.5% from 33.7%.
Total assets under management were $90.9 billion, down 1.0% from a year ago. Open-end funds averaged higher assets and fees, driving advisory and administration fees to $133.6 million (up 6.6%). Distribution and service fees were $7.5 million. Expenses increased 5.1% to $92.8 million, led by distribution, service, and general and administrative costs.
Cash and cash equivalents were $98.1 million as of September 30, 2025. The company amended its revolving credit facility to $100.0 million maturing August 15, 2029. Subsequent events included a closed-end fund rights offering that raised approximately $353.2 million in proceeds (fund level) and a declared quarterly dividend of $0.62 per share payable November 20, 2025 to holders of record on November 10, 2025.
Cohen & Steers (CNS): Executive Chairman and 10% owner Robert H. Steers reported multiple open‑market purchases of common stock on Oct 20–22, 2025, primarily through family trusts. Examples include the Robert H. Steers 2018 Revocable Trust buying 6,382 shares at a $69.50 weighted average and 5,557 shares at $71.30. The Hilltop GST Non‑Exempt Descendants' Trust reported buys such as 5,204 shares at $69.44 and 5,434 shares at $71.31. Post‑trade, indirect holdings shown include 7,060,084 shares (Revocable Trust) and 3,858,709 shares (Hilltop Trust).
Cohen & Steers, Inc. (CNS) insider transaction: The company’s Interim CFO and SVP reported an acquisition of 2,154 shares of common stock on 10/17/2025 at a reported price of $0, tied to a grant of restricted stock units (RSUs). Following the transaction, the reporting person beneficially owns 26,018 shares directly.
The RSUs vest ratably over four years. Any dividends paid on the common stock are paid as additional RSUs, and those dividend RSUs vest on the fourth anniversary of the original RSU grant date.
Cohen & Steers, Inc. (CNS) filed a Form 3 reporting its Interim CFO and SVP’s beneficial ownership. The officer directly owns 23,864 shares of common stock. This amount includes 17,604 restricted stock units previously granted. The filing is tied to the event date 10/17/2025, and ownership is reported as direct.
Cohen & Steers, Inc. furnished an 8-K announcing the availability of its results for the quarter ended September 30, 2025. The company provided an earnings announcement (Exhibit 99.1) and a full earnings release (Exhibit 99.2).
The Item 2.02 information, including the exhibits, is being furnished—not filed—under the Exchange Act.
Reena Aggarwal, a director of Cohen & Steers, Inc. (CNS), reported a stock award transaction dated 10/01/2025. The filing shows acquisition of 423 shares of common stock resulting from restricted stock units granted by the issuer at a $0 per-share price, and the reporting person holds 16,185 shares following the transaction. The RSUs were 100% vested on the grant date, with the underlying shares to be delivered on the third anniversary of the grant date. The Form 4 was filed by one reporting person and signed on behalf of the reporting person by an attorney-in-fact on 10/03/2025.
Edmond D. Villani, a director of Cohen & Steers, Inc. (CNS), reported multiple equity transactions in early October 2025. On 10/01/2025 he was granted 423 restricted stock units that were 100% vested on the grant date and will be delivered on the third anniversary of the grant. On 10/03/2025 he reported transferring 4,589 shares to the Edmond Dennis Villani Revocable Trust and also a reportable acquisition showing the trust holds 30,259 shares. Following the transactions, Dr. Villani directly owned 5,021 shares and the trust held the stated indirect position. The filings were signed by an attorney-in-fact on 10/03/2025.
FAQ
What is the current stock price of Cohen & Steers (CNS)?
What is the market cap of Cohen & Steers (CNS)?
